|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19 EUR | -0.52% |
|
-1.40% | +2.70% |
| Apr. 19 | Jefferies raises target for Evonik to €20 - 'Hold' | DP |
| Apr. 19 | EVONIK : Jefferies reaffirms its Neutral rating | ZD |
(Reuters) - German chemicals group Evonik is aiming for above 4% annual organic growth in the medium term, up from earlier target of over 3%, the company said on Wednesday.
It also targets a margin on adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of between 18% and 20%, Chief Financial Officer Ute Wolf said in a statement released ahead of the company's Capital Markets Day.
(Reporting by Karol Badohal and Bartosz Dabrowski in Gdansk; editing by Milla Nissi)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.70% | 9.51B | |
| +10.81% | 63.12B | |
| +12.69% | 40.45B | |
| +17.66% | 26.45B | |
| +4.77% | 18.31B | |
| -0.95% | 17.34B | |
| -21.87% | 16.71B | |
| +0.28% | 15.55B | |
| -20.42% | 13.55B | |
| +31.94% | 12.94B |
EVONIK INDUSTRIES AG 
